The abstract is read at the publisher; the summary is JClub's.
Diastolic function measured in human iPSC-cardiomyocytes carrying TNNI3 variants correlates with disease severity, with age at onset linked by R² = 0.6 in patients from a single site.
- Why it matters: Most cardiomyopathy variants’ effects on physiology and clinical outcomes are unclear, limiting mechanism discovery and targeted therapy development.
- What they did: The study built a high-throughput iPSC-cardiomyocyte platform integrating systolic/diastolic force generation with calcium handling to distinguish pathogenic from nonpathogenic TNNI3 variants and to assess variants of uncertain significance.
- The result: In patients with TNNI3 cardiomyopathy from one site, in vitro diastolic function correlates with age at onset, enabling variant effect profiling that aligns with clinical severity and may support class-targeted treatment discovery.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.